WO2023073526 - METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY
National phase entry:
Publication Number
WO/2023/073526
Publication Date
04.05.2023
International Application No.
PCT/IB2022/060189
International Filing Date
24.10.2022
Title **
[English]
METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY
[French]
MÉTHODES POUR AMÉLIORER L'ADMINISTRATION DE VIRUS ADÉNO-ASSOCIÉ (VAA)
Applicants **
NOVARTIS AG
Inventors
MANSFIELD, Keith
Priority Data
63/271,487
25.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6788 | |
| EPO | Filing, Examination, Granting | 181951 | |
| Japan | Filing, Examination, Granting | 5175 | |
| South Korea | Filing, Examination, Granting | 11520 | |
| USA | Filing, Examination, Granting | 38390 |
Total:
243,824
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are methods for improving delivery of a pharmaceutical composition to the central nervous system of a subject in need thereof, the method comprising administering to the subject an agent that enhances glymphatic influx in combination with the pharmaceutical composition.[French]
L'invention concerne des méthodes pour améliorer l'administration d'une composition pharmaceutique au système nerveux central d'un sujet en ayant besoin, la méthode comprenant l'administration au sujet d'un agent qui améliore l'influx glymphatique en combinaison avec la composition pharmaceutique.